Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

Related Citations for PubMed (Select 24315966)

1.

Clinical characteristics and outcomes of elderly patients treated with an implantable cardioverter-defibrillator or cardiac resynchronization therapy in a real-world setting: data from the Israeli ICD Registry.

Suleiman M, Goldenberg I, Haim M, Schliamser JE, Boulos M, Ilan M, Swissa M, Gavrielov-Yusim N, Fuchs T, Amit G, Glikson M; Israeli Working Group on Pacing and Electrophysiology.

Heart Rhythm. 2014 Mar;11(3):435-41. doi: 10.1016/j.hrthm.2013.12.003. Epub 2013 Dec 4.

PMID:
24315966
2.

Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.

Wilcox JE, Fonarow GC, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW.

Circ Heart Fail. 2014 Jan;7(1):146-53. doi: 10.1161/CIRCHEARTFAILURE.113.000789. Epub 2013 Oct 31.

3.

The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).

Ruwald AC, Pietrasik G, Goldenberg I, Kutyifa V, Daubert JP, Ruwald MH, Jons C, McNitt S, Wang P, Zareba W, Moss AJ.

J Am Coll Cardiol. 2014 Apr 1;63(12):1190-7. doi: 10.1016/j.jacc.2013.10.074. Epub 2013 Dec 11.

PMID:
24333490
4.

Implantable cardioverter-defibrillator prescription in the elderly.

Epstein AE, Kay GN, Plumb VJ, McElderry HT, Doppalapudi H, Yamada T, Shafiroff J, Syed ZA, Shkurovich S; ACT Investigators.

Heart Rhythm. 2009 Aug;6(8):1136-43. doi: 10.1016/j.hrthm.2009.04.010. Epub 2009 Apr 10.

PMID:
19539542
5.

The Clinical Course of Patients with Implantable Defibrillators; Extended Experience on Clinical Outcome, Device Replacements and Device-Related Complications.

van der Heijden AC, Borleffs CJ, Buiten MS, Thijssen J, van Rees JB, Cannegieter SC, Schalij MJ, van Erven L.

Heart Rhythm. 2015 Mar 3. pii: S1547-5271(15)00255-6. doi: 10.1016/j.hrthm.2015.02.035. [Epub ahead of print]

PMID:
25749138
6.

Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.

Masoudi FA, Mi X, Curtis LH, Peterson PN, Curtis JP, Fonarow GC, Hammill SC, Heidenreich PA, Al-Khatib SM, Piccini JP, Qualls LG, Hernandez AF.

Ann Intern Med. 2014 May 6;160(9):603-11. doi: 10.7326/M13-1879.

PMID:
24798523
7.

Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry.

Wasmer K, Köbe J, Andresen D, Zahn R, Spitzer SG, Jehle J, Brachmann J, Stellbrink C, Martens E, Hochadel M, Senges J, Klein H, Eckardt L.

Clin Res Cardiol. 2013 Jul;102(7):513-21. doi: 10.1007/s00392-013-0559-0. Epub 2013 Mar 30.

PMID:
23543113
8.

Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry.

Ziaeian B, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC.

J Am Coll Cardiol. 2014 Aug 26;64(8):797-807. doi: 10.1016/j.jacc.2014.05.060.

9.

Outcome of Patients with Advanced Heart Failure who Receive Device-Based Therapy for Primary Prevention of Sudden Cardiac Death: Insights from the Israeli ICD Registry.

Suleiman M, Goldenberg I, Samniah N, Rosso R, Marai I, Pekar A, Khalameizer V, Militianu A, Glikson M.

Pacing Clin Electrophysiol. 2015 Mar 10. doi: 10.1111/pace.12627. [Epub ahead of print]

PMID:
25754272
10.

Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.

Arnson Y, Suleiman M, Glikson M, Sela R, Geist M, Amit G, Schliamser JE, Goldenberg I, Ben-Zvi S, Orvin K, Rosenheck S, Adam Freedberg N, Strasberg B, Haim M.

Heart Rhythm. 2014 May;11(5):814-21. doi: 10.1016/j.hrthm.2014.01.030. Epub 2014 Jan 30.

PMID:
24486799
11.

Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.

Doyle CL, Huang DT, Moss AJ, Solomon SD, Campbell P, McNitt S, Polonsky S, Barsheshet A, Aktas M, Tompkins C, Zareba W, Goldenberg I.

Heart Rhythm. 2013 Oct;10(10):1471-7. doi: 10.1016/j.hrthm.2013.07.029. Epub 2013 Jul 19.

PMID:
23872690
12.

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.

Schuchert A, Muto C, Maounis T, Frank R, Boulogne E, Polauck A, Padeletti L; MASCOT study group.

Europace. 2013 Jan;15(1):71-6. doi: 10.1093/europace/eus247. Epub 2012 Aug 26.

13.

Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes?

Hess PL, Mi X, Curtis LH, Wilkoff BL, Hegland DD, Al-Khatib SM.

Heart Rhythm. 2013 Aug;10(8):1127-33. doi: 10.1016/j.hrthm.2013.06.009. Epub 2013 Jun 14.

14.

Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.

Köbe J, Wasmer K, Andresen D, Kleemann T, Spitzer SG, Jehle J, Brachmann J, Stellbrink C, Hochadel M, Senges J, Klein HU, Eckardt L.

Int J Cardiol. 2013 Oct 9;168(4):4184-90. doi: 10.1016/j.ijcard.2013.07.110. Epub 2013 Aug 12.

PMID:
23948108
15.

Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.

Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL.

J Am Coll Cardiol. 2013 Oct 29;62(18):1674-9. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27.

16.

Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.

Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM.

JAMA. 2009 Apr 22;301(16):1661-70. doi: 10.1001/jama.2009.547.

17.

Effectiveness of cardiac resynchronization therapy with defibrillator in at-risk black and white cardiac patients.

Elanchenny M, Moss AJ, McNitt S, Aktas M, Polonsky S, Zareba W, Goldenberg I.

Ann Noninvasive Electrocardiol. 2013 Mar;18(2):140-8. doi: 10.1111/anec.12006. Epub 2012 Nov 22.

PMID:
23530484
18.

Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.

Morani G, Gasparini M, Zanon F, Casali E, Spotti A, Reggiani A, Bertaglia E, Solimene F, Molon G, Accogli M, Tommasi C, Paoletti Perini A, Ciardiello C, Padeletti L.

Europace. 2013 Sep;15(9):1273-9. doi: 10.1093/europace/eut032. Epub 2013 Feb 24.

19.

Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias.

Manfredi JA, Al-Khatib SM, Shaw LK, Thomas L, Fogel RI, Padanilam B, Rardon D, Vatthyam R, Gemma LW, Golden K, Prystowsky EN.

Circ Arrhythm Electrophysiol. 2013 Apr;6(2):257-64. doi: 10.1161/CIRCEP.112.000214. Epub 2013 Feb 26.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk